OA03.08 Activity of Ensartinib after Second Generation Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors (TKI): Topic: Medical OncologyLeora Horn, T. Leal,Geoffrey R. Oxnard,Heather A. Wakelee,George R. Blumenschein,Saiama N. Waqar,L. Gandhi,A.A. Chiappori,Gary Dukart,Kimberly Harrow,Chris Liang,F. Tan,Jon Gockerman,Karen L. ReckampJournal of Thoracic Oncology（2017）引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
